149 related articles for article (PubMed ID: 37404820)
1. Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency.
Ying D; Niu W; Chen Y; Wang Y; Tian W; Zhang X; Liu C; Wang S; Chen Z; Lin Y; Guo S; Yu Z; Chen X; Fang M; Qiang H; Yin Y; Tang Z; Zheng Z; Fu L; Xia N
Front Immunol; 2023; 14():1183859. PubMed ID: 37404820
[TBL] [Abstract][Full Text] [Related]
2. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection.
Kemming J; Gundlach S; Panning M; Huzly D; Huang J; Lütgehetmann M; Pischke S; Schulze Zur Wiesch J; Emmerich F; Llewellyn-Lacey S; Price DA; Tanriver Y; Warnatz K; Boettler T; Thimme R; Hofmann M; Fischer N; Neumann-Haefelin C
J Hepatol; 2022 Oct; 77(4):978-990. PubMed ID: 35636577
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis E virus infection and fulminant hepatic failure during pregnancy.
Jilani N; Das BC; Husain SA; Baweja UK; Chattopadhya D; Gupta RK; Sardana S; Kar P
J Gastroenterol Hepatol; 2007 May; 22(5):676-82. PubMed ID: 17444855
[TBL] [Abstract][Full Text] [Related]
5. Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques.
Bremer W; Blasczyk H; Yin X; Salinas E; Grakoui A; Feng Z; Walker C
J Hepatol; 2021 Sep; 75(3):557-564. PubMed ID: 33961939
[TBL] [Abstract][Full Text] [Related]
6. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.
Cao D; Cao QM; Subramaniam S; Yugo DM; Heffron CL; Rogers AJ; Kenney SP; Tian D; Matzinger SR; Overend C; Catanzaro N; LeRoith T; Wang H; Piñeyro P; Lindstrom N; Clark-Deener S; Yuan L; Meng XJ
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6914-6923. PubMed ID: 28630341
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection.
Colson P; Dhiver C; Gérolami R
Clin Microbiol Infect; 2008 Dec; 14(12):1176-80. PubMed ID: 19046170
[TBL] [Abstract][Full Text] [Related]
8. Distinct disease features of acute and persistent genotype 3 hepatitis E virus infection in immunocompetent and immunosuppressed Mongolian gerbils.
Subramaniam S; Fares-Gusmao R; Sato S; Cullen JM; Takeda K; Farci P; McGivern DR
PLoS Pathog; 2023 Sep; 19(9):e1011664. PubMed ID: 37703304
[TBL] [Abstract][Full Text] [Related]
9. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
[TBL] [Abstract][Full Text] [Related]
10. CD8
Rogers E; Todd SM; Pierson FW; Kenney SP; Heffron CL; Yugo DM; Matzinger SR; Mircoff E; Ngo I; Kirby C; Jones M; Siegel P; Jobst P; Hall K; Etches RJ; Meng XJ; LeRoith T
J Med Virol; 2019 Nov; 91(11):1960-1969. PubMed ID: 31317546
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection.
Suneetha PV; Pischke S; Schlaphoff V; Grabowski J; Fytili P; Gronert A; Bremer B; Markova A; Jaroszewicz J; Bara C; Manns MP; Cornberg M; Wedemeyer H
Hepatology; 2012 Mar; 55(3):695-708. PubMed ID: 22006345
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis E virus infection in patients infected with the human immunodeficiency virus.
Kaba M; Richet H; Ravaux I; Moreau J; Poizot-Martin I; Motte A; Nicolino-Brunet C; Dignat-George F; Ménard A; Dhiver C; Brouqui P; Colson P
J Med Virol; 2011 Oct; 83(10):1704-16. PubMed ID: 21837786
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient.
Chen Z; Wei J; Jiang L; Ying D; Tian W; Zhang M; Wen G; Wang S; Liu C; Wang Y; Wu T; Tang Z; Zheng Z; Yan L; Xia N
Front Immunol; 2022; 13():954697. PubMed ID: 36275730
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.
Brown A; Halliday JS; Swadling L; Madden RG; Bendall R; Hunter JG; Maggs J; Simmonds P; Smith DB; Vine L; McLaughlin C; Collier J; Bonsall D; Jeffery K; Dunachie S; Klenerman P; Izopet J; Kamar N; Dalton HR; Barnes E
Hepatology; 2016 Dec; 64(6):1934-1950. PubMed ID: 27631819
[TBL] [Abstract][Full Text] [Related]
15. Brief communication: case reports of ribavirin treatment for chronic hepatitis E.
Mallet V; Nicand E; Sultanik P; Chakvetadze C; Tessé S; Thervet E; Mouthon L; Sogni P; Pol S
Ann Intern Med; 2010 Jul; 153(2):85-9. PubMed ID: 20547886
[TBL] [Abstract][Full Text] [Related]
16. Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors.
Kraef C; Schlein C; Hiller J; Westhölter D; Denzer U; Horvatits T; Peine S; Lohse AW; Lütgehetmann M; Polywka S; Pischke S
J Clin Virol; 2018 Aug; 105():26-30. PubMed ID: 29860111
[TBL] [Abstract][Full Text] [Related]
17. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
[TBL] [Abstract][Full Text] [Related]
18. Immunobiology and Host Response to HEV.
Zhou Y
Adv Exp Med Biol; 2016; 948():113-141. PubMed ID: 27738982
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection.
Elkady A; Tanaka Y; Kurbanov F; Hirashima N; Sugiyama M; Khan A; Kato H; Okumura A; Mizokami M
J Gastroenterol; 2007 Nov; 42(11):911-7. PubMed ID: 18008036
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
